Aggressive prostate cancer is prevented in ERαKO mice and stimulated in ERβKO TRAMP mice

Endocrinology

Volumn 153, Issue 9, 2012, Pages 4160-4170

  Sĺusarz, Anna ^a,d   Jackson, Glenn A ^b,d   Day, J Kevin ^b,d,e   Shenouda, Nader S ^a,d   Bogener, Jennifer L ^a,d   Browning, Jim D ^b   Fritsche, Kevin L ^b,d   MacDonald, Ruth S ^c   Besch Williford, Cynthia L ^b   Lubahn, Dennis B ^a,b,d  

^a University of Missouri   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c IOWA STATE UNIVERSITY   (United States)

^d MU Center for Botanical Interaction Studies   (United States)

^e MIRACA LIFE SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENISTEIN; PHYTOESTROGEN; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; DRUG BLOOD LEVEL; DRUG MEGADOSE; ESTRADIOL BLOOD LEVEL; ESTROGEN ACTIVITY; GENOTYPE; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; LOW DRUG DOSE; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; TESTOSTERONE BLOOD LEVEL; TRANSGENIC MOUSE; TUMOR DIFFERENTIATION; WILD TYPE;

ANIMALS; DISEASE MODELS, ANIMAL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENISTEIN; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, KNOCKOUT; PROSTATIC NEOPLASMS;

EID: 84865423001     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2012-1030     Document Type: Article

References (84)

1. Mukamel E, Nissenkorn I, Servadio C 1980 Early combined hormonal and chemotherapy for metastatic carcinoma of prostate. Urology 16:257-260 (Pubitemid 11195715)
2. Huggins C, Hodges CV 2002 Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941. J Urol 168:9-12
3. Karr JP, Wajsman Z, Kirdani RY, Murphy GP, Sandberg AA 1980 Effects of diethylstilbestrol and estramustine phosphate on serum sex hormone binding globulin and testosterone levels in prostate cancer patients. J Urol 124:232-236 (Pubitemid 10045592)
4. Klugo RC, Farah RN, Cerny JC 1981 Bilateral orchiectomy for carcinoma of prostate. Response of serum testosterone and clinical response to subsequent estrogen therapy. Urology 17:49-50 (Pubitemid 11167946)
5. Kemp HA, Read GF, Riad-Fahmy D, Pike AW, Gaskell SJ, Queen K, Harper ME, Griffiths K 1981 Measurement of diethylstilbestrol in plasma from patients with cancer of the prostate. Cancer Res 41: 4693-4697 (Pubitemid 12201392)
6. Jarred RA, Cancilla B, Prins GS, Thayer KA, Cunha GR, Risbridger GP 2000 Evidence that estrogens directly alter androgen-regulated prostate development. Endocrinology 141:3471-3477 (Pubitemid 32269037)
7. Prins GS, Korach KS 2008 The role of estrogens and estrogen receptors in normal prostate growth and disease. Steroids 73:233-244
8. Setchell KD, Cassidy A 1999 Dietary isoflavones: biological effects and relevance to human health. J Nutr 129:758S-767S
9. Knight DC, Eden JA 1996 A review of the clinical effects of phytoestrogens. Obstet Gynecol 87:897-904 (Pubitemid 26127148)
10. Jian L 2009 Soy, isoflavones, and prostate cancer. Mol Nutr Food Res 53:217-226
11. Steiner C, Arnould S, Scalbert A, Manach C 2008 Isoflavones and the prevention of breast and prostate cancer: new perspectives opened by nutrigenomics. Br J Nutr 99(E Suppl 1):ES78-ES108
12. Iwasaki M, Inoue M, Otani T, Sasazuki S, Kurahashi N, Miura T, Yamamoto S, Tsugane S 2008 Plasma isoflavone level and subsequent risk of breast cancer among Japanese women: a nested casecontrol study from the Japan public health center-based prospective study group. J Clin Oncol 26:1677-1683
13. Kurahashi N, Iwasaki M, Sasazuki S, Otani T, Inoue M, Tsugane S 2007 Soy product and isoflavone consumption in relation to prostate cancer in Japanese men. Cancer Epidemiol Biomarkers Prev 16:538-545 (Pubitemid 46548658)
14. Hamilton-Reeves JM, Rebello SA, Thomas W, Kurzer MS, Slaton JW 2008 Effects of soy protein isolate consumption on prostate cancer biomarkers in men with HGPIN, ASAP, and low-grade prostate cancer. Nutr Cancer 60:7-13 (Pubitemid 351192916)
15. Shenouda NS, Zhou C, Browning JD, Ansell PJ, Sakla MS, Lubahn DB, Macdonald RS 2004 Phytoestrogens in common herbs regulate prostate cancer cell growth in vitro. Nutr Cancer 49:200-208 (Pubitemid 39487880)
16. Peterson G, Barnes S 1993 Genistein and biochanin A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor tyrosine autophosphorylation. Prostate 22:335-345 (Pubitemid 23176275)
17. Slusarz A, Shenouda NS, Sakla MS, Drenkhahn SK, Narula AS, MacDonald RS, Besch-Williford CL, Lubahn DB 2010 Common botanical compounds inhibit the hedgehog signaling pathway in prostate cancer. Cancer Res 70:3382-3390
18. Banerjee S, Li Y, Wang Z, Sarkar FH 2008 Multi-targeted therapy of cancer by genistein. Cancer Lett 269:226-242
19. Kuiper GG, Carlsson B, Grandien K, Enmark E, Häggblad J, Nilsson S, Gustafsson JA 1997 Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 138:863-870 (Pubitemid 27089735)
20. Chang WY, Prins GS 1999 Estrogen receptor-β: implications for the prostate gland. Prostate 40:115-124 (Pubitemid 29304702)
21. Prins GS, Marmer M, Woodham C, Chang W, Kuiper G, Gustafsson JA, Birch L 1998 Estrogen receptor-β messenger ribonucleic acid ontogeny in the prostate of normal and neonatally estrogenized rats. Endocrinology 139:874-883 (Pubitemid 28510101)
22. Prins GS, Birch L, Couse JF, Choi I, Katzenellenbogen B, Korach KS 2001 Estrogen imprinting of the developing prostate gland is mediated through stromal estrogen receptor α: studies with αERKO and βERKO mice. Cancer Res 61:6089-6097 (Pubitemid 32762544)
23. Prins GS, Birch L 1995 The developmental pattern of androgen receptor expression in rat prostate lobes is altered after neonatal exposure to estrogen. Endocrinology 136:1303-1314
24. Prins GS, Birch L 1997 Neonatal estrogen exposure up-regulates estrogen receptor expression in the developing and adult rat prostate lobes. Endocrinology 138:1801-1809 (Pubitemid 27180792)
25. Prins GS, Woodham C, Lepinske M, Birch L 1993 Effects of neonatal estrogen exposure on prostatic secretory genes and their correlation with androgen receptor expression in the separate prostate lobes of the adult rat. Endocrinology 132:2387-2398 (Pubitemid 23156886)
26. Prins GS 1992 Neonatal estrogen exposure induces lobe-specific alterations in adult rat prostate androgen receptor expression. Endocrinology 130:2401-2412
27. Driscoll SG, Taylor SH 1980 Effects of prenatal maternal estrogen on the male urogenital system. Obstet Gynecol 56:537-542 (Pubitemid 11238201)
28. Risbridger G, Wang H, Young P, Kurita T, Wang YZ, Lubahn D, Gustafsson JA, Cunha G, Wong YZ 2001 Evidence that epithelial and mesenchymal estrogen receptor-α mediates effects of estrogen on prostatic epithelium. Dev Biol 229:432-442 (Pubitemid 32108703)
29. Greenberg NM, DeMayo F, Finegold MJ, Medina D, Tilley WD, Aspinall JO, Cunha GR, Donjacour AA, Matusik RJ, Rosen JM 1995 Prostate cancer in a transgenic mouse. Proc Natl Acad Sci USA 92:3439-3443
30. Greenberg NM, DeMayo FJ, Sheppard PC, Barrios R, Lebovitz R, Finegold M, Angelopoulou R, Dodd JG, Duckworth ML, Rosen JM, et al 1994 The rat probasin gene promoter directs hormonally and developmentally regulated expression of a heterologous gene specifically to the prostate in transgenic mice. Mol Endocrinol 8:230-239 (Pubitemid 24067110)
31. Sharma A, Yeow WS, Ertel A, Coleman I, Clegg N, Thangavel C, Morrissey C, Zhang X, Comstock CE, Witkiewicz AK, Gomella L, Knudsen ES, Nelson PS, Knudsen KE 2010 The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression. J Clin Invest 120:4478-4492
32. Navone NM, Troncoso P, Pisters LL, Goodrow TL, Palmer JL, Nichols WW, von Eschenbach AC, Conti CJ 1993 p53 protein accumulation and gene mutation in the progression of human prostate carcinoma. J Natl Cancer Inst 85:1657-1669
33. Guo JY, Li X, Browning Jr JD, Rottinghaus GE, Lubahn DB, Constantinou A, Bennink M, MacDonald RS 2004 Dietary soy isoflavones and estrone protect ovariectomized ERαKO and wild-type mice from carcinogen-induced colon cancer. J Nutr 134:179-182 (Pubitemid 38057444)
34. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, Fukami Y 1987 Genistein, a specific inhibitor of tyrosine- specific protein kinases. J Biol Chem 262:5592-5595
35. Shappell SB, Thomas GV, Roberts RL, Herbert R, Ittmann MM, Rubin MA, Humphrey PA, Sundberg JP, Rozengurt N, Barrios R, Ward JM, Cardiff RD 2004 Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the mouse models of human cancer consortium prostate pathology committee. Cancer Res 64:2270-2305 (Pubitemid 38339483)
36. Kaplan-Lefko PJ, Chen TM, Ittmann MM, Barrios RJ, Ayala GE, Huss WJ, Maddison LA, Foster BA, Greenberg NM 2003 Pathobiology of autochthonous prostate cancer in a pre-clinical transgenic mouse model. Prostate 55:219-237 (Pubitemid 36532401)
37. Shenouda NS, Sakla MS, Newton LG, Besch-Williford C, Greenberg NM, MacDonald RS, Lubahn DB 2007 Phytosterol Pygeum africanum regulates prostate cancer in vitro and in vivo. Endocrine 31:72-81 (Pubitemid 350194198)
38. Yu L, Blackburn GL, Zhou JR 2003 Genistein and daidzein downregulate prostate androgen-regulated transcript-1 (PART-1) gene expression induced by dihydrotestosterone in human prostate LNCaP cancer cells. J Nutr 133:389-392 (Pubitemid 36172888)
39. Couse JE, Mahato D, Eddy EM, Korach KS 2001 Molecular mechanism of estrogen action in the male: insights from the estrogen receptor null mice. Reprod Fertil Dev 13:211-219 (Pubitemid 33133341)
40. Gupta L, Thakur H, Sobti RC, Seth A, Singh SK 2010 Role of genetic polymorphism of estrogen receptor-α gene and risk of prostate cancer in north Indian population. Mol Cell Biochem 335:255-261
41. Mentor-Marcel R, Lamartiniere CA, Eltoum IE, Greenberg NM, Elgavish A 2001 Genistein in the diet reduces the incidence of poorly differentiated prostatic adenocarcinoma in transgenic mice (TRAMP). Cancer Res 61:6777-6782 (Pubitemid 32896500)
42. Gaido KW, Maness SC, McDonnell DP, Dehal SS, Kupfer D, Safe S 2000 Interaction of methoxychlor and related compounds with estrogen receptor α and β, and androgen receptor: structure-activity studies. Mol Pharmacol 58:852-858
43. Carroll VM, Jeyakumar M, Carlson KE, Katzenellenbogen JA 2012 Diarylpropionitrile (DPN) enantiomers: synthesis and evaluation of estrogen receptor β-selective ligands. J Med Chem 55:528-537
44. Meyers MJ, Sun J, Carlson KE, Marriner GA, Katzenellenbogen BS, Katzenellenbogen JA 2001 Estrogen receptor-β potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. J Med Chem 44: 4230-4251 (Pubitemid 33095330)
45. Stauffer SR, Coletta CJ, Tedesco R, Nishiguchi G, Carlson K, Sun J, Katzenellenbogen BS, Katzenellenbogen JA 2000 Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor- α-selective agonists. J Med Chem 43:4934-4947 (Pubitemid 32040974)
46. Gaido KW, Leonard LS, Maness SC, Hall JM, McDonnell DP, Saville B, Safe S 1999 Differential interaction of the methoxychlor metabolite 2,2-bis-(p-hydroxyphenyl)-1,1,1-trichloroethane with estrogen receptors α and β. Endocrinology 140:5746-5753 (Pubitemid 30648838)
47. Zhang Y, Song TT, Cunnick JE, Murphy PA, Hendrich S 1999 Daidzein and genistein glucuronides in vitro are weakly estrogenic and activate human natural killer cells at nutritionally relevant concentrations. J Nutr 129:399-405 (Pubitemid 29072127)
48. Cave NJ, Backus RC, Marks SL, Klasing KC 2007 Oestradiol, but not genistein, inhibits the rise in food intake following gonadectomy in cats, but genistein is associated with an increase in lean body mass. J Anim Physiol Anim Nutr 91:400-410 (Pubitemid 47382867)
49. Onderci M, Sahin K, Sahin N, Gursu MF, Doerge D, Sarkar FH, Kucuk O 2004 The effect of genistein supplementation on performance and antioxidant status of Japanese quail under heat stress. Arch Anim Nutr 58:463-471 (Pubitemid 40126157)
50. Chiaverotti T, Couto SS, Donjacour A, Mao JH, Nagase H, Cardiff RD, Cunha GR, Balmain A 2008 Dissociation of epithelial and neuroendocrine carcinoma lineages in the transgenic adenocarcinoma of mouse prostate model of prostate cancer. Am J Pathol 172:236-246 (Pubitemid 351186384)
51. Leung YK, Lam HM, Wu S, Song D, Levin L, Cheng L, Wu CL, Ho SM 2010 Estrogen receptor β2 and β5 are associated with poor prognosis in prostate cancer, and promote cancer cell migration and invasion. Endocr Relat Cancer 17:675-689
52. Kelly MJ, Wagner EJ 1999 Estrogen modulation of G-protein-coupled receptors. Trends Endocrinol Metab 10:369-374 (Pubitemid 29496011)
53. Aronica SM, Kraus WL, Katzenellenbogen BS 1994 Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription. Proc Natl Acad Sci USA 91:8517-8521 (Pubitemid 24273695)
54. Razandi M, Pedram A, Greene GL, Levin ER 1999 Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ERα and ERβ expressed in Chinese hamster ovary cells. Mol Endocrinol 13:307-319 (Pubitemid 29068005)
55. Chambliss KL, Yuhanna IS, Anderson RG, Mendelsohn ME, Shaul PW 2002 ERβ has nongenomic action in caveolae. Mol Endocrinol 16:938-946
56. Pedram A, Razandi M, Wallace DC, Levin ER 2006 Functional estrogen receptors in the mitochondria of breast cancer cells. Mol Biol Cell 17:2125-2137 (Pubitemid 44011729)
57. Hu WY, Shi GB, Lam HM, Hu DP, Ho SM, Madueke IC, Kajdacsy- Balla A, Prins GS 2011 Estrogen-initiated transformation of prostate epithelium derived from normal human prostate stem-progenitor cells. Endocrinology 152:2150-2163
58. Ellem SJ, Risbridger GP 2009 The dual, opposing roles of estrogen in the prostate. Ann NY Acad Sci 1155:174-186
59. McPherson SJ, Ellem SJ, Simpson ER, Patchev V, Fritzemeier KH, Risbridger GP 2007 Essential role for estrogen receptor β in stromalepithelial regulation of prostatic hyperplasia. Endocrinology 148: 566-574 (Pubitemid 46143161)
60. Jia S, Zhang X, He DZ, Segal M, Berro A, Gerson T, Wang Z, Casale TB 2011 Expression and function of a novel variant of estrogen receptor-ER-α36 in mouse airway. Am J Respir Cell Mol Biol 45: 1084-1089
61. Chakravarty D, Nair SS, Santhamma B, Nair BC, Wang L, Bandyopadhyay A, Agyin JK, Brann D, Sun LZ, Yeh IT, Lee FY, Tekmal RR, Kumar R, Vadlamudi RK 2010 Extranuclear functions of ER impact invasive migration and metastasis by breast cancer cells. Cancer Res 70:4092-4101
62. Gingrich JR, Barrios RJ, Kattan MW, Nahm HS, Finegold MJ, Greenberg NM 1997 Androgen-independent prostate cancer progression in the TRAMP model. Cancer Res 57:4687-4691 (Pubitemid 27468967)
63. Bono AV, Montironi R, Pannellini T, Sasso F, Mirone V, Musiani P, Iezzi M 2008 Effects of castration on the development of prostate adenocarcinoma from its precursor HGPIN and on the occurrence of androgen-independent, poorly differentiated carcinoma in TRAMP mice. Prostate Cancer Prostatic Dis 11:377-383
64. Beck V, Unterrieder E, Krenn L, Kubelka W, Jungbauer A 2003 Comparison of hormonal activity (estrogen, androgen and progestin) of standardized plant extracts for large scale use in hormone replacement therapy. J Steroid Biochem Mol Biol 84:259-268 (Pubitemid 36514843)
65. Nagata C, Inaba S, Kawakami N, Kakizoe T, Shimizu H 2000 Inverse association of soy product intake with serum androgen and estrogen concentrations in Japanese men. Nutr Cancer 36:14-18 (Pubitemid 30317830)
66. Kao YC, Zhou C, Sherman M, Laughton CA, Chen S 1998 Molecular basis of the inhibition of human aromatase (estrogen synthetase) by flavone and isoflavone phytoestrogens: a site-directed mutagenesis study. Environ Health Perspect 106:85-92 (Pubitemid 28143862)
67. Rissman EF, Wersinger SR, Taylor JA, Lubahn DB 1997 Estrogen receptor function as revealed by knockout studies: neuroendocrine and behavioral aspects. Horm Behav 31:232-243 (Pubitemid 27305721)
68. Bektic J, Berger AP, Pfeil K, Dobler G, Bartsch G, Klocker H 2004 Androgen receptor regulation by physiological concentrations of the isoflavonoid genistein in androgen-dependent LNCaP cells is mediated by estrogen receptor β. Eur Urol 45:245-251; discussion 251
69. Wang J, Eltoum IE, Lamartiniere CA 2007 Genistein chemoprevention of prostate cancer in TRAMP mice. J Carcinog 6:3
70. Maggiolini M, Vivacqua A, Carpino A, Bonofiglio D, Fasanella G, Salerno M, Picard D, Ando S 2002 The mutant androgen receptor T877A mediates the proliferative but not the cytotoxic dose-dependent effects of genistein and quercetin on human LNCaP prostate cancer cells. Mol Pharmacol 62:1027-1035 (Pubitemid 35229971)
71. Bhattacharyya RS, Krishnan AV, Swami S, Feldman D 2006 Fulvestrant (ICI 182,780) down-regulates androgen receptor expression and diminishes androgenic responses in LNCaP human prostate cancer cells. Mol Cancer Ther 5:1539-1549 (Pubitemid 44070491)
72. King KJ, Nicholson HD, Assinder SJ 2006 Effect of increasing ratio of estrogen: androgen on proliferation of normal human prostate stromal and epithelial cells, and the malignant cell line LNCaP. Prostate 66:105-114 (Pubitemid 43005954)
73. Dakhova O, Ozen M, Creighton CJ, Li R, Ayala G, Rowley D, Ittmann M 2009 Global gene expression analysis of reactive stroma in prostate cancer. Clin Cancer Res 15:3979-3989
74. Karhadkar SS, Bova GS, Abdallah N, Dhara S, Gardner D, Maitra A, Isaacs JT, Berman DM, Beachy PA 2004 Hedgehog signalling in prostate regeneration, neoplasia and metastasis. Nature 431:707-712 (Pubitemid 39382619)
75. Fan L, Pepicelli CV, Dibble CC, Catbagan W, Zarycki JL, Laciak R, Gipp J, Shaw A, Lamm ML, Munoz A, Lipinski R, Thrasher JB, Bushman W 2004 Hedgehog signaling promotes prostate xenograft tumor growth. Endocrinology 145:3961-3970 (Pubitemid 39037585)
76. Sanchez P, Hernández AM, Stecca B, Kahler AJ, DeGueme AM, Barrett A, Beyna M, Datta MW, Datta S, Ruiz i Altaba A 2004 Inhibition of prostate cancer proliferation by interference with SONIC HEDGEHOG-GLI1 signaling. Proc Natl Acad Sci USA 101: 12561-12566 (Pubitemid 39122063)
77. Sheng T, Li C, Zhang X, Chi S, He N, Chen K, McCormick F, Gatalica Z, Xie J 2004 Activation of the hedgehog pathway in advanced prostate cancer. Mol Cancer 3:29
78. Su Y, Simmen RC 2009 Soy isoflavone genistein upregulates epithelial adhesion molecule E-cadherin expression and attenuates β-catenin signaling in mammary epithelial cells. Carcinogenesis 30: 331-339
79. Matsumura K, Tanaka T, Kawashima H, Nakatani T 2008 Involvement of the estrogen receptor β in genistein-induced expression of p21(waf1/cip1) in PC-3 prostate cancer cells. Anticancer Res 28: 709-714 (Pubitemid 351578912)
80. Chang EC, Charn TH, Park SH, Helferich WG, Komm B, Katzenellenbogen JA, Katzenellenbogen BS 2008 Estrogen receptors α and β as determinants of gene expression: influence of ligand, dose, and chromatin binding. Mol Endocrinol 22:1032-1043 (Pubitemid 351629605)
81. Razandi M, Pedram A, Merchenthaler I, Greene GL, Levin ER 2004 Plasma membrane estrogen receptors exist and functions as dimers. Mol Endocrinol 18:2854-2865 (Pubitemid 39577911)
82. Weihua Z, Lathe R, Warner M, Gustafsson JA 2002 An endocrine pathway in the prostate, ERβ, AR, 5α-androstane-3β,17β-diol, and CYP7B1, regulates prostate growth. Proc Natl Acad Sci USA 99: 13589-13594 (Pubitemid 35221316)
83. Dondi D, Piccolella M, Biserni A, Della Torre S, Ramachandran B, Locatelli A, Rusmini P, Sau D, Caruso D, Maggi A, Ciana P, Poletti A 2010 Estrogen receptor β and the progression of prostate cancer: role of 5α-androstane-3β,17β-diol. Endocr Relat Cancer 17:731-742
84. Guerini V, Sau D, Scaccianoce E, Rusmini P, Ciana P, Maggi A, Martini PG, Katzenellenbogen BS, Martini L, Motta M, Poletti A 2005 The androgen derivative 5α-androstane-3β,17β-diol inhibits prostate cancer cell migration through activation of the estrogen receptor β subtype. Cancer Res 65:5445-5453